Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 521

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 521
---
 periodically reviewed for recoverability when impairment indicators are present. F-41

Details of property and equipment are presented as follows (in thousands):

|                             |     |   | September 30, 
          2024 |   |     |   | December 31, 
         2023 |   |
|:----------------------------|:----|:--|--------------:|:--|:----|:--|-------------:|:--|
| Computers and software      |     | $ |           471 |   |     | $ |          464 |   |
| Construction in process     |     |   |         5,704 |   |     |   |        4,389 |   |
| Furniture and fixtures      |     |   |            65 |   |     |   |           65 |   |
| Lab equipment               |     |   |            25 |   |     |   |           25 |   |
| Leasehold improvements      |     |   |           133 |   |     |   |          129 |   |
| Total                       |     | $ |         6,398 |   |     | $ |        5,072 |   |
| Accumulated depreciation    |     |   |          (416 | ) |     |   |         (270 | ) |
| Property and equipment, net |     | $ |         5,982 |   |     | $ |        4,802 |   |

Construction in process mainly consists of lab, production, and testing equipment. Depreciation expense on property, plant, and equipment amounted to $47,000 and $44,000 for the three months ended September 30, 2024 and 2023, respectively. Depreciation expense on property, plant, and equipment amounted to $0.1 million and $0.1 million for the nine months ended September 30, 2024 and 2023, respectively. Leases At the inception of a contractual arrangement, the Company determines whether the contract contains a lease by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset in exchange for consideration over a period of time. If both criteria are met, the Company records the associated lease liability and corresponding right-of-useasset upon commencement of the lease using the implicit rate or a discount rate based on a credit-adjusted secured borrowing rate commensurate with the term of the lease. The